Last reviewed · How we verify
NCT07430189: PuRe-axSpA
Multimodal Pulmonary Rehabilitation in Radiographic Axial Spondyloarthritis
NA trial testing Multimodal Pulmonary Rehabilitation in Axial Spondyloarthritis (AxSpA) in 20 participants. Completed in 30 September 2020.
30 September 2020
Quick facts
| Lead sponsor | Balikesir University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 30 May 2018 |
| Primary completion | 30 September 2020 |
| Estimated completion | 30 September 2020 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Multimodal Pulmonary Rehabilitation
Conditions studied
- Axial Spondyloarthritis (AxSpA) — all drugs for Axial Spondyloarthritis (AxSpA) →
Sponsor
Balikesir University
Who can join
Adults 18 to 75, any sex, with Axial Spondyloarthritis (AxSpA). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This prospective pilot study aims to evaluate the efficacy of a structured 8-week multimodal pulmonary rehabilitation (PR) program specifically designed for patients with radiographic axial spondyloarthritis (r-axSpA). The study assesses the impact of a composite intervention incorporating aerobic conditioning, resistance training, flexibility protocols, and targeted diaphragmatic breathing on functional exercise capacity, dyspnea severity, and pulmonary function.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07430189
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Axial Spondyloarthritis (AxSpA)
Currently open trials in the same condition.
- NCT07160231 — REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases · Phase 4 · recruiting
- NCT07047703 — EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1) · Phase 1, PHASE2 · recruiting
Other Balikesir University trials
Trials by the same sponsor.
- NCT07048093 — Development of Standard Guidelines for Relaxation Exercises in Patients With Chronic Neck Pain and Determination of Thei · NA · not yet recruiting
- NCT06812481 — Anticholinergic Burden and Osteoporosis in Rheumatoid Arthritis · recruiting
- NCT06856395 — Effect of Using Educational Robots During Vaccination on Fear and Pain in Children · NA · not yet recruiting
- NCT07103837 — Development, Validity, and Reliability of the Reactive Skill Test in Older Adults · NA · completed
- NCT07203924 — Prognostic Importance of Physical Activity in Geriatric Patients With Acute Coronary Syndrome · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07430189 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Balikesir University
- Last refreshed: 25 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07430189.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing